Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Midwife-Led Digital Follow-Up After Cesarean Section

NCT07523932 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-06-15
Last updated
2026-09-14

Condition(s) studied

Postpartum DepressionBreastfeedingPostpartum Period

Investigational drug(s) / intervention(s)

Midwife-Led Digital Follow-Up Program

Midwife-Led Digital Follow-Up Program: Participants will receive a structured face-to-face education session on the first postpartum day followed by a 4-week digital follow-up program including weekly educational messages, individualized counseling, and continuous support via mobile communication platforms.

Study summary

This randomized controlled trial aims to evaluate the effect of a midwife-led digital follow-up program on postpartum depression, perceived social support, and breastfeeding self-efficacy in women who will undergo cesarean section.

Participants will be randomly assigned to either an intervention group that will receive structured face-to-face education followed by a 4-week digital follow-up program, or a control group that will receive routine postpartum care.

Data will be collected at baseline (postpartum day 1), at 1 week, and at 4 weeks postpartum using validated measurement tools.

The study will provide evidence on the effectiveness of continuous, midwife-led digital support in improving maternal psychological well-being and breastfeeding outcomes in the early postpartum period.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Women aged between 18 and 45 years * Women who have undergone cesarean section * Within the first 24 hours postpartum * Able to communicate in Turkish * Having a healthy singleton newborn * Willing to participate and provide informed consent Exclusion Criteria: * History of psychiatric disorders * Presence of severe maternal complications * Newborn requiring intensive care unit admission * Women with communication difficulties * Participation in another intervention study

Primary outcome measure(s)

  • Postpartum Depression — Baseline (first postpartum day), 1 week postpartum, and 4 weeks postpartum
    Postpartum depression will be measured using the Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report scale with total scores ranging from 0 to 30. Higher scores will indicate more severe depressive symptoms.
  • Perceived Social Support — Baseline (first postpartum day), 1 week postpartum, and 4 weeks postpartum
    Perceived social support will be measured using the Multidimensional Scale of Perceived Social Support (MSPSS), a 12-item scale with total scores ranging from 12 to 84. Higher scores will indicate greater perceived social support.
  • Breastfeeding Self-Efficacy — Baseline, 1 week, and 4 weeks postpartum
    Breastfeeding self-efficacy will be measured using the Breastfeeding Self-Efficacy Scale (BSES), a 33-item scale with total scores ranging from 33 to 165. Higher scores will indicate higher breastfeeding self-efficacy.

Trial sites (1)

FacilityCityRegionStatus
Giresun University Giresun Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07523932 on ClinicalTrials.gov ↗ ← All trials in Turkey